Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.

@article{Murteira2013DrugRA,
  title={Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.},
  author={Susana Murteira and Zied Ghezaiel and Slim Karray and Michel Lamure},
  journal={Journal of market access & health policy},
  year={2013},
  volume={1}
}
BACKGROUND Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed products can be named as repositioned or reformulated products, respectively. Market access of repositioned or reformulated products in Europe and the United States is an interesting object of study as it may provide clarity about which… CONTINUE READING
7 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…